Kathryn E Luker Selected Research

Kathryn E Luker Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 07/2003
20	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2004
20	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2004
5	Infections 10/2011 - 10/2005
4	Triple Negative Breast Neoplasms 12/2019 - 11/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 12/2011
3	Virus Diseases (Viral Diseases) 04/2010 - 10/2005
3	Vaccinia 09/2008 - 10/2005
2	Atherosclerosis 11/2013 - 03/2012
1	Carcinogenesis 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	HIV Infections (HIV Infection) 11/2013
1	Lyme Disease (Disease, Lyme) 10/2011
1	Circulating Neoplastic Cells 07/2008
1	Respiratory Syncytial Virus Infections 12/2007
1	Lung Neoplasms (Lung Cancer) 10/2007
1	Poxviridae Infections 06/2007
1	Focal Infection 10/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2003
1	Herpes Simplex 04/2002
1	Carcinoma (Carcinomatosis) 04/2002

Drug/Important Bio-Agent (IBA)

9	Chemokine CXCL12IBA 01/2018 - 10/2009
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2005
7	LuciferasesIBA 01/2022 - 06/2008
7	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2018 - 06/2009
6	LigandsIBA 02/2021 - 12/2004
6	Chemokine ReceptorsIBA 01/2019 - 12/2004
5	ChemokinesIBA 01/2019 - 10/2007
5	Firefly LuciferasesIBA 12/2011 - 10/2005
4	Phosphotransferases (Kinase)IBA 02/2021 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 07/2008
4	CollagenIBA 01/2019 - 07/2014
3	EnzymesIBA 01/2022 - 06/2008
3	beta-Arrestin 1IBA 01/2022 - 03/2012
3	Pharmaceutical PreparationsIBA 10/2018 - 11/2013
3	plerixafor FDA Link 01/2013 - 12/2004
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2021 - 01/2019
2	NAD (NADH)IBA 01/2020 - 01/2019
2	HydrogelsIBA 01/2019 - 01/2018
2	Caspase 3 (Caspase-3)IBA 06/2018 - 12/2017
2	Biological ProductsIBA 06/2018 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015 - 07/2003
1	Pyruvate KinaseIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 02/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021
1	ErbB Receptors (EGF Receptor)IBA 02/2021
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Thioredoxin-Disulfide ReductaseIBA 01/2020
1	MK 2206IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019
1	Bovine Serum AlbuminIBA 12/2019
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	NanogelsIBA 01/2019
1	Fibrillar CollagensIBA 01/2019
1	GelsIBA 01/2019
1	AlginatesIBA 01/2018
1	nanolucIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	FSH Receptors (FSH Receptor)IBA 10/2016
1	Monoclonal AntibodiesIBA 10/2016
1	graphene oxideIBA 10/2016
1	Glutamine (L-Glutamine)FDA Link 12/2015
1	EpitopesIBA 11/2015
1	POL5551IBA 11/2015
1	eribulin FDA Link 11/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	haloalkane dehalogenase (alkylhalidase)IBA 01/2015
1	AntigensIBA 05/2013
1	Isoantigens (Alloantigen)IBA 05/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	CXC ChemokinesIBA 03/2012
1	Coloring Agents (Dyes)IBA 01/2012
1	Green Fluorescent ProteinsIBA 12/2011
1	VaccinesIBA 10/2011
1	OspA proteinIBA 10/2011
1	beta-Arrestin 2IBA 10/2009
1	Toll-Like Receptor 4IBA 09/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008
1	Antiviral Agents (Antivirals)IBA 06/2008
1	CytokinesIBA 12/2007
1	Interleukin-12 Subunit p40IBA 12/2007
1	Clodronic Acid (Clodronate)IBA 06/2007
1	InterferonsIBA 10/2005
1	Interferon Type IIBA 10/2005
1	UbiquitinIBA 07/2003
1	Proteasome InhibitorsIBA 07/2003
1	Bortezomib (Velcade)FDA Link 07/2003
1	enhanced green fluorescent proteinIBA 04/2002

Therapy/Procedure

17	Therapeutics 02/2021 - 06/2008
4	Drug Therapy (Chemotherapy) 06/2016 - 08/2015
2	Lab-On-A-Chip Devices 12/2019 - 06/2009
1	Intravenous Injections 10/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2013
1	Cell Transplantation 05/2013
1	Immunotherapy 05/2013